This website is intended for healthcare professionals only

Trending Topic

16 mins

Trending Topic

Developed by Touch
Mark CompleteCompleted
BookmarkBookmarked

Hypertension is the leading modifiable risk factor for global cardiovascular disease, responsible for an estimated 10.8 million deaths and more than 200 million disability-adjusted life years annually.1 Despite the availability of effective pharmacological and lifestyle interventions, prevalence continues to rise, particularly in low- and middle-income countries (LMICs), where over three-quarters of all cases now occur.2 The condition’s […]

Organic nitrates and tolerance in cardiovascular diseases: effects of isosorbide-2-mononitrate compared to traditional nitrates

Riccardo Raddino, Giorgio Caretta, Debora Robba, Gregoriana Zanini, Ivano Bonadei, Alberto Madureri, Livio Dei Cas
< 1 min
Share
Facebook
X (formerly Twitter)
LinkedIn
Via Email
Mark CompleteCompleted
BookmarkBookmarked
Copy LinkLink Copied
Download as PDF
Published Online: Jul 30th 2018 Heart International 2007;3(3-4):112-21
Select a Section…
1

Abstract

Overview

Nitrates are a cornerstone in the treatment of coronary heart disease and heart failure.
Although they are widely used in clinical practice, their therapeutic value is partially compromised
by the rapid development of tolerance. The effect of different nitrates, nitroglycerin
(NTG), isosorbide dinitrate (ISDN), 5-mononitrate (5MN) and 2-mononitrate (2MN) and the mechanism
responsible for nitrate tolerance were investigated on isolated rabbit hearts and aortic
strips. Preparation was stimulated by different spasmogenic agents: KCl, angiotensin II (A) and
noradrenaline (NA); nitrates were administered on the plateau contraction, at the concentration
of maximum inhibitory effect. Nitrates produced the following maximum inhibitions on NA-induced
contraction: NTG 90% (10–6 M), ISDN 60% (10–4 M), 5MN 55% (10–4 M) and 2MN 80%
(10–4 M). In another series of experiments, preparations were pre-incubated with the maximum
inhibitory concentration of each nitrate to evaluate the induction of tolerance. After incubation a
loss of vasodilator effect of nearly 50-60% was observed for all the nitrates considered except
2MN, in which the loss of effect was significantly lower (36%). The cyclic GMP (cGMP) levels
measured in the preparations were lower in the presence of 2MN than in the other compounds.
These data suggest that 2MN is able to induce a lesser cGMP increase and a lesser tolerance induction;
since these observations seem to be correlated the vasodilator effect of 2MN probably involves
mechanisms other than guanylyl cyclase stimulation. (Heart International 2007; 3: 112-21)

Keywords

Nitroglycerine, Tolerance induction, Nitric oxide, Isosorbide mononitrate

2

Article Information

Correspondence

Prof. Riccardo Raddino, Section of Cardiovascular Diseases – Department of Applied, Experimental Medicine, University of Brescia, Operative Unit of Cardiology, “Spedali Civili” Hospital, Brescia – Italy, riccardo.raddino@libero.it

3

Further Resources

Share
Facebook
X (formerly Twitter)
LinkedIn
Via Email
Mark CompleteCompleted
BookmarkBookmarked
Copy LinkLink Copied
Download as PDF
Close Popup